News

Select Year
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
July 30, 2020 6:05 AM
EDT
2020
Aurinia Pharmaceuticals to Report Second Quarter 2020 Financial Results on August 11, 2020
Download
July 27, 2020 10:15 AM
EDT
2020
Aurinia Closes US$200 Million Public Offering of Common Shares
Download
July 22, 2020 11:05 PM
EDT
2020
Aurinia Prices US$200 Million Public Offering of Common Shares
Download
July 22, 2020 4:08 PM
EDT
2020
Aurinia Announces Public Offering of Common Shares
Download
July 21, 2020 5:27 PM
EDT
2020
Aurinia Announces U.S. Food and Drug Administration Acceptance of the Filing of New Drug Application and Priority Review for Voclosporin for the Treatment of Lupus Nephritis
Download
June 22, 2020 6:05 AM
EDT
2020
Aurinia Completes Patient Enrollment Into the AUDREY Phase 2/3 Clinical Trial of Voclosporin Ophthalmic Solution for the Treatment of Dry Eye Syndrome
Download
June 9, 2020 6:05 AM
EDT
2020
Aurinia Presents Additional AURORA Pivotal Trial Safety Data at the ERA-EDTA Virtual Congress 2020
Download
June 5, 2020 7:05 AM
EDT
2020
Aurinia Presents AURORA Pivotal Trial Subgroup Analysis at the EULAR 2020 E-Congress
Download
June 3, 2020 6:05 AM
EDT
2020
Aurinia Announces Results of Annual General Meeting
Download
June 1, 2020 4:05 PM
EDT
2020
Aurinia Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
Download
May 26, 2020 6:05 AM
EDT
2020
Aurinia Completes Submission of New Drug Application to the U.S. Food & Drug Administration for Voclosporin for the Treatment of Lupus Nephritis
Download
May 15, 2020 4:05 PM
EDT
2020
Aurinia Pharmaceuticals to Present at 2020 RBC Capital Markets’ Virtual Global Healthcare Conference
Download
May 14, 2020 4:02 PM
EDT
2020
Aurinia Reports First Quarter 2020 Financial Results and Recent Operational Highlights
Download
May 7, 2020 6:05 AM
EDT
2020
Aurinia Pharmaceuticals to Release First Quarter 2020 Financial Results on May 14, 2020
Download
April 27, 2020 6:05 AM
EDT
2020
Aurinia Appoints Joe Miller as Chief Financial Officer
Download
April 20, 2020 6:05 AM
EDT
2020
Aurinia Appoints Industry Veteran Timothy P. Walbert to its Board of Directors
Download
March 18, 2020 6:05 AM
EDT
2020
Aurinia Announces AURORA Phase 3 Clinical Data for Voclosporin in Lupus Nephritis to be Presented at National Kidney Foundation 2020 Spring Clinical Meetings
Download
March 17, 2020 6:00 AM
EDT
2020
Aurinia Pharmaceuticals Establishes U.S. Commercial Operations Center in Rockville, Maryland
Download
March 16, 2020 6:05 AM
EDT
2020
Aurinia Pharmaceuticals Initiates Rolling Submission of a New Drug Application to the U.S. Food and Drug Administration for Voclosporin in the Treatment of Lupus Nephritis
Download
March 12, 2020 7:00 AM
EDT
2020
Aurinia Launches Resource Kit for People Living With Lupus Nephritis and Partners With National Kidney Foundation on Awareness Initiative
Download
March 5, 2020 4:02 PM
EST
2020
Aurinia Reports Fourth Quarter and Full Year 2019 Financial Results and Operational Highlights
Download
March 3, 2020 6:30 AM
EST
2020
Aurinia Pharmaceuticals to Release Fourth Quarter and Full Year 2019 Financial Results on March 5, 2020
Download
February 25, 2020 6:30 AM
EST
2020
Aurinia Appoints Max Colao as Chief Commercial Officer and Expands U.S. Commercial Leadership Team
Download
February 21, 2020 4:05 PM
EST
2020
Aurinia Pharmaceuticals to Present at the 9th Annual SVB Leerink Global Healthcare Conference
Download
December 12, 2019 9:26 AM
EST
2019
Aurinia Closes US$191.7 Million Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Common Shares
Download
No Results Found
Please try different keywords or filters.

Email Alerts

By providing your email address above, you are providing consent to Aurinia Pharmaceuticals Inc. to send you the requested Investor Email Alert updates. For information on how we protect your information, please refer to our Privacy Policy.
Thank you! Your message has been sent!
Oops! There was an error with your submission.